Prothrombin time tests
This article was originally published in The Gray Sheet
Executive Summary
HCFA formally opens national coverage review for home-use PT tests Jan. 29. Medicare coverage is currently left to the discretion of the four durable medical equipment regional carriers, which have consistently denied claims (1"The Gray Sheet" Aug. 28, 2000, p. 3). The current review likely will focus on patients with mechanical valves and those with atrial fibrillation who have suffered a cardiovascular event. Comments are due by April 24, 2001
You may also be interested in...
HCFA Raising Curtain On PT Self Testing; Roche Bows Out Prior To Showtime
HCFA will initiate a national coverage review of home-use prothrombin time tests within the next month, but has not yet determined whether the Medicare Coverage Advisory Committee will be called on for a recommendation on the issue.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.